Cargando…

A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment

Mild cognitive impairment (MCI) impacts approximately 20% of older adults, with many also experiencing sleep disorders, such as insomnia. Given the relationship between sleep and dementia, addressing sleep issues may offer an opportunity to treat reversible causes. There are two primary treatments f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattos, Meghan K, Chang, Angela, Pitcher, Katherine, Whitt, Carley, Ritterband, Lee M, Quigg, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219491/
https://www.ncbi.nlm.nih.gov/pubmed/34221547
http://dx.doi.org/10.14336/AD.2021.0423
_version_ 1783710939282931712
author Mattos, Meghan K
Chang, Angela
Pitcher, Katherine
Whitt, Carley
Ritterband, Lee M
Quigg, Mark S
author_facet Mattos, Meghan K
Chang, Angela
Pitcher, Katherine
Whitt, Carley
Ritterband, Lee M
Quigg, Mark S
author_sort Mattos, Meghan K
collection PubMed
description Mild cognitive impairment (MCI) impacts approximately 20% of older adults, with many also experiencing sleep disorders, such as insomnia. Given the relationship between sleep and dementia, addressing sleep issues may offer an opportunity to treat reversible causes. There are two primary treatments for insomnia: behavioral-based (cognitive behavioral therapy for insomnia, CBT-I) and pharmacological interventions. Although CBT-I is recommended as first-line treatment for insomnia in older adults, sedative-hypnotics are more likely to be recommended than non-pharmacological treatments given their convenience and accessibility. However, there are significant concerns in prescribing medications to patients with MCI. To explore this disconnect, we reviewed insomnia treatments in older adults with MCI studies and current guidelines of pharmacological therapy. First, we reviewed studies presenting non-pharmacological treatment of insomnia in older adults with MCI. Although the search yielded over 4,000 non-duplicate titles, only one article presented data on non-pharmacological treatment of insomnia in MCI. The literature covering comorbid insomnia, CBT-I, and MCI is sparse. In contrast to review of non-pharmacological studies, studies on the pharmacological treatment of insomnia in older adults were ample. Finally, we reviewed international guidelines for pharmacological treatment of insomnia in cognitive disorders. More widely used pharmacological interventions show short-term effectiveness with problems of recurrence, ineffectiveness in inadvertent or purposeful chronic use, and adverse side effects. Despite evidence regarding adverse consequences, pharmacological treatment of insomnia remains the most common treatment for insomnia. Reflecting on age-related changes in older adults, particularly those with MCI, inappropriate or mismanagement of medication can lead to unnecessary complications. Further research examining effective behavioral-based sleep management options in older adults with cognitive impairment is needed with exploration of improved sleep on cognitive function.
format Online
Article
Text
id pubmed-8219491
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-82194912021-07-03 A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment Mattos, Meghan K Chang, Angela Pitcher, Katherine Whitt, Carley Ritterband, Lee M Quigg, Mark S Aging Dis Review Mild cognitive impairment (MCI) impacts approximately 20% of older adults, with many also experiencing sleep disorders, such as insomnia. Given the relationship between sleep and dementia, addressing sleep issues may offer an opportunity to treat reversible causes. There are two primary treatments for insomnia: behavioral-based (cognitive behavioral therapy for insomnia, CBT-I) and pharmacological interventions. Although CBT-I is recommended as first-line treatment for insomnia in older adults, sedative-hypnotics are more likely to be recommended than non-pharmacological treatments given their convenience and accessibility. However, there are significant concerns in prescribing medications to patients with MCI. To explore this disconnect, we reviewed insomnia treatments in older adults with MCI studies and current guidelines of pharmacological therapy. First, we reviewed studies presenting non-pharmacological treatment of insomnia in older adults with MCI. Although the search yielded over 4,000 non-duplicate titles, only one article presented data on non-pharmacological treatment of insomnia in MCI. The literature covering comorbid insomnia, CBT-I, and MCI is sparse. In contrast to review of non-pharmacological studies, studies on the pharmacological treatment of insomnia in older adults were ample. Finally, we reviewed international guidelines for pharmacological treatment of insomnia in cognitive disorders. More widely used pharmacological interventions show short-term effectiveness with problems of recurrence, ineffectiveness in inadvertent or purposeful chronic use, and adverse side effects. Despite evidence regarding adverse consequences, pharmacological treatment of insomnia remains the most common treatment for insomnia. Reflecting on age-related changes in older adults, particularly those with MCI, inappropriate or mismanagement of medication can lead to unnecessary complications. Further research examining effective behavioral-based sleep management options in older adults with cognitive impairment is needed with exploration of improved sleep on cognitive function. JKL International LLC 2021-07-01 /pmc/articles/PMC8219491/ /pubmed/34221547 http://dx.doi.org/10.14336/AD.2021.0423 Text en copyright: © 2021 Mattos et al. https://creativecommons.org/licenses/by/2.0/this is an open access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Review
Mattos, Meghan K
Chang, Angela
Pitcher, Katherine
Whitt, Carley
Ritterband, Lee M
Quigg, Mark S
A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title_full A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title_fullStr A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title_full_unstemmed A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title_short A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment
title_sort review of insomnia treatments for patients with mild cognitive impairment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219491/
https://www.ncbi.nlm.nih.gov/pubmed/34221547
http://dx.doi.org/10.14336/AD.2021.0423
work_keys_str_mv AT mattosmeghank areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT changangela areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT pitcherkatherine areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT whittcarley areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT ritterbandleem areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT quiggmarks areviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT mattosmeghank reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT changangela reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT pitcherkatherine reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT whittcarley reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT ritterbandleem reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment
AT quiggmarks reviewofinsomniatreatmentsforpatientswithmildcognitiveimpairment